Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy.

Toshiko KoboriYukiko OnishiYoko YoshidaTazu TaharaTakako KikuchiTetsuya KubotaMasahiko IwamotoTomonobu SawadaReo KobayashiHiroaki FujiwaraMasato Kasuga

Published in: Journal of diabetes investigation (2023)

GLP-1RA treatment is associated with gastric residue in an esophagogastroduodenoscopy in patients with diabetes.

Keyphrases

rheumatoid arthritis
combination therapy
disease activity
ankylosing spondylitis
amino acid
idiopathic pulmonary fibrosis
interstitial lung disease